cbdMD (NYSEAMERICAN:YCBD) Stock Price Up 0.5%

cbdMD, Inc. (NYSEAMERICAN:YCBD) rose 0.5% on Thursday . The company traded as high as $2.05 and last traded at $2.03. Approximately 80,737 shares traded hands during mid-day trading, a decline of 85% from the average daily volume of 549,637 shares. The stock had previously closed at $2.02.

Separately, Cantor Fitzgerald reiterated a “neutral” rating and set a $3.25 target price (down from $4.10) on shares of cbdMD in a research note on Friday, June 18th.

The firm’s 50-day simple moving average is $2.88. The firm has a market capitalization of $116.84 million, a PE ratio of -3.64 and a beta of 1.69.

cbdMD (NYSEAMERICAN:YCBD) last issued its quarterly earnings data on Thursday, August 12th. The company reported $0.02 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.06. The firm had revenue of $10.56 million during the quarter. cbdMD had a negative net margin of 57.40% and a negative return on equity of 32.68%. Sell-side analysts forecast that cbdMD, Inc. will post -0.09 EPS for the current year.

A number of institutional investors have recently modified their holdings of YCBD. BlackRock Inc. boosted its holdings in shares of cbdMD by 58.2% during the 1st quarter. BlackRock Inc. now owns 722,713 shares of the company’s stock valued at $2,992,000 after purchasing an additional 265,825 shares during the last quarter. Cambria Investment Management L.P. boosted its holdings in shares of cbdMD by 42.3% during the 1st quarter. Cambria Investment Management L.P. now owns 94,868 shares of the company’s stock valued at $393,000 after purchasing an additional 28,204 shares during the last quarter. AdvisorShares Investments LLC boosted its holdings in shares of cbdMD by 58.7% during the 1st quarter. AdvisorShares Investments LLC now owns 2,284,128 shares of the company’s stock valued at $9,456,000 after purchasing an additional 844,403 shares during the last quarter. Davy Global Fund Management Ltd boosted its holdings in shares of cbdMD by 227.5% during the 1st quarter. Davy Global Fund Management Ltd now owns 161,283 shares of the company’s stock valued at $668,000 after purchasing an additional 112,035 shares during the last quarter. Finally, Acadian Asset Management LLC bought a new position in shares of cbdMD during the 1st quarter valued at about $44,000. 18.25% of the stock is owned by institutional investors.

cbdMD Company Profile (NYSEAMERICAN:YCBD)

cbdMD, Inc produces and distributes various cannibidiol (CBD) products. It operates the consumer hemp-based CBD brand. The firms product categories include CBD tinctures, capsules, gummies, bath bombs, topical creams, and animal treats and oils. It also offers pet related CBD products under the Paw CBD brand name, and distributes its products through an e-commerce Website, wholesalers, and various brick and mortar retailers in the United States.

Featured Article: When is a capital gain realized?

Receive News & Ratings for cbdMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for cbdMD and related companies with MarketBeat.com's FREE daily email newsletter.